Word abonnee en neem Beursduivel Premium
Rode planeet als pijlen grid met hoorntjes Beursduivel

Océ Terug naar discussie overzicht

Rokus van Iperen interviewed by Reuters Announ

1 Post
| Omlaag ↓
  1. Doe maar 21 september 2000 16:41
    Rokus van Iperen interviewed by Reuters Announces profit-growth target of more than 10 percent Venlo, September 21, 2000 — “We have set a profit-growth target of more than 10 percent, which may or may not include currency effects or acquisitions”, Océ Chairman Rokus van Iperen said in an interview with Reuters. Océ autonomous growth this year is five percent. Mr Van Iperen continued, “We hope we can enhance that autonomous growth next year by launching new products and increasing our activities in growth markets.” In addition to six new printers and scanners, Océ will launch as many as a dozen new software products. ‘There is no reason whatsoever to believe that profit growth will be disappointing”, said Mr. Van Iperen. “I’m clearly more optimistic than at the start of the year, and that optimism hasn’t changed since seeing our earnings for the first half of the year. The restructuring, product development, and investment in growth markets are bearing fruit. “Printing on demand (PoD) is an extremely important market for us. It’s the fastest growing segment, with annual growth of roughly 60 to 70 percent. PoD currently accounts for 10 percent of sales in Production Printing Systems (PPS) and in two years it should account for 25 percent of sales in this strategic business unit.” Océ aims to supplement its PoD assortment, which includes a range of machines that print from 440 to 1,060 pages per minute. Price competition in Document Printing Systems continues, with competition coming primarily from the other players: Xerox, Canon and HP. According to Reuters, this probably explains why Xerox is facing such difficulties. Yet there are differences between Océ and others in this market. While Xerox and Canon derive a major part of their sales from the office market, office systems account for just 50 percent of Océ total sales. In addition, Xerox and Canon are primarily active in the highly competitive low volume segments and Océ in the more-profitable higher volume segments. “The other two professional markets (Production Printing and Wide Format Printing) are stable and provide a basis for growth”, Mr. Van Iperen told Reuters. “By reducing service-cost margins we’re leaving more room to deal with fierce price competition.”
1 Post
|Omhoog ↑

Neem deel aan de discussie

Word nu gratis lid van Beursduivel.be

Al abonnee? Log in

Direct naar Forum

Zoek alfabetisch op forum

  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
Forum # Topics # Posts
Aalberts 465 6.846
AB InBev 2 5.303
Abionyx Pharma 2 29
Ablynx 43 13.356
ABN AMRO 1.580 46.944
ABO-Group 1 19
Acacia Pharma 9 24.692
Accell Group 151 4.129
Accentis 2 253
Accsys Technologies 22 9.025
ACCSYS TECHNOLOGIES PLC 218 11.686
Ackermans & van Haaren 1 160
ADMA Biologics 1 32
Adomos 1 126
AdUX 2 457
Adyen 13 16.597
Aedifica 2 832
Aegon 3.257 320.306
AFC Ajax 537 7.025
Affimed NV 2 5.777
ageas 5.843 109.782
Agfa-Gevaert 13 1.888
Ahold 3.536 74.015
Air France - KLM 1.024 34.385
Airspray 511 1.258
Akka Technologies 1 18
AkzoNobel 466 12.778
Alfen 13 16.846
Allfunds Group 3 1.233
Almunda Professionals (vh Novisource) 651 4.247
Alpha Pro Tech 1 17
Alphabet Inc. 1 340
Altice 106 51.196
Alumexx ((Voorheen Phelix (voorheen Inverko)) 8.485 114.771
AM 228 684
Amarin Corporation 1 133
Amerikaanse aandelen 3.821 240.462
AMG 965 126.453
AMS 3 73
Amsterdam Commodities 303 6.527
AMT Holding 199 7.047
Anavex Life Sciences Corp 2 383
Antonov 22.632 153.605
Aperam 91 14.182
Apollo Alternative Assets 1 17
Apple 5 322
Arcadis 251 8.628
Arcelor Mittal 2.024 318.754
Archos 1 1
Arcona Property Fund 1 268
arGEN-X 15 9.175
Aroundtown SA 1 184
Arrowhead Research 5 9.305
Ascencio 1 20
ASIT biotech 2 697
ASMI 4.107 37.763
ASML 1.762 77.495
ASR Nederland 18 4.161
ATAI Life Sciences 1 7
Atenor Group 1 335
Athlon Group 121 176
Atrium European Real Estate 2 199
Auplata 1 55
Avantium 29 10.773
Axsome Therapeutics 1 177
Azelis Group 1 49
Azerion 7 2.681

Beleggingsideeën van onze partners

Macro & Bedrijfsagenda

  1. 17 mei

    1. Japan economische groei Q1
    2. China detailhandelsverkopen april
    3. China industriële productie april
    4. Sif Q1-cijfers
    5. Engie Q1-cijfers
    6. Corbion ex €0,61 dividend
    7. EU inflatie april (def)
    8. VS voorlopende indicatoren april
  2. 20 mei

    1. Dui, producentenprijzen april
    2. Ryanair jaarcijfers
de volitaliteit verwacht indicator betekend: Market moving event/hoge(re) volatiliteit verwacht